Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/INCYTE-CORPORATION-9675/news/Incyte-meldet-positive-Ergebnisse-des-Phase-3-Programms-TRuE-V-in-dem-Ruxolitinib-Creme-bei-Patie-33281201/?utm_source=whatsapp&utm_medium=social&utm_campaign=share